Chemotherapy-Induced Peripheral Neuropathy Impacts Quality Of Life And Activities Of Daily Living Of Brazilian Multiple Myeloma Patients.

Paula Lana de Miranda Drummond Roberta Márcia Marques Dos Santos Lívia Pena Silveira Jéssica Soares Malta Adriano Max Moreira Reis Naiane Lima Costa Roberta Oliveira de Paula E Silva Evandro Maranhão Fagundes Cristiane Aparecida Menezes de Pádua

Published in: Current drug safety (2023)

MM patients showed a high frequency of CIPN, which affected ADL and impaired HRQoL. Early and accurate detection of CIPN and dose management in patients with thalidomide and bortezomib-based regimens should be performed to provide better treatment outcomes and avoid permanent disabilities.

Keyphrases

high frequency
end stage renal disease
newly diagnosed
multiple myeloma
chemotherapy induced
ejection fraction
chronic kidney disease
high resolution
patient reported outcomes
patient reported